General MedicationsVAGINALGeneric
MILPROSA
PROGESTERONE
Standard Dose
1.78GM
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview MILPROSA is listed in Drugs@FDA under application 201110 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient PROGESTERONE Form and strength SYSTEM;VAGINAL - 1.78GM Sponsor FERRING PHARMS INC Submission history Latest submission status date: 2020-04-29 00:00:00.
Structured Monograph
Clinical summary
Approval overview MILPROSA is listed in Drugs@FDA under application 201110 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient PROGESTERONE Form and strength SYSTEM;VAGINAL - 1.78GM Sponsor FERRING PHARMS INC Submission history Latest submission status date: 2020-04-29 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.